Marcaine Injection, Solution
Product Images NDC 0409-2253

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Marcaine (NDC 0409-2253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Marcaine 01)

Chemical structure of Marcaine (bupivacaine), including a piperidine ring attached to an amide bond connected to a methylphenyl group, shown with hydrochloride and water of hydration components.*

FDA Label Image

Structural Formula Epinephrine (Marcaine 02)

Chemical structure diagram depicting the active ingredient of Marcaine and its associated compound. The image shows two molecular structures side by side, representing the chemical composition related to this drug product by Hospira, Inc.*

FDA Label Image

Hospira Logo (Marcaine 03)

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label)

Label for Marcaine 0.25% bupivacaine HCl injection, USP, 25 mg/10 mL (2.5 mg/mL) single-dose vial. The label indicates the product is preservative-free and intended for infiltration, nerve block, caudal, and epidural anesthesia. It is distributed by Hospira, Inc., Lake Forest, IL, USA. The label includes storage instructions, lot number, expiration date, and barcode.*

FDA Label Image

Carton Ndc 0409-1559-10 (Marcaine 05)

Packaging label for Marcaine 0.25% (bupivacaine HCl injection, USP) 25 mg/10 mL preservative-free single-dose vials. The label indicates a package containing 10 single-dose vials, with directions for use including storage temperature and dosage. Distributed by Hospira, Inc., the label also specifies the product is for infiltration, nerve block, caudal, and epidural anesthesia but not for intrathecal anesthesia.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Marcaine 0.25% (bupivacaine HCl injection, USP) 75 mg/30 mL single-dose vial preservative free. The label indicates the solution is for infiltration, nerve block, caudal, and epidural anesthesia but not for intrathecal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. Includes NDC, lot, and expiration date placeholders.*

FDA Label Image

Carton Ndc 0409-1560-10 (Marcaine 07)

Packaging label for Marcaine 0.25% bupivacaine HCl injection, USP, with a strength of 75 mg/30 mL (2.5 mg/mL). The label indicates it contains 10 single-dose preservative-free vials and is for infiltration, nerve block, caudal, and epidural anesthesia, with a note that it is not for intrathecal anesthesia. The product is distributed by Hospira, Inc. and made in Sweden.*

FDA Label Image

Principal Display Panel (75 mg/10 mL Vial Label)

Label for Marcaine 0.5% (bupivacaine HCl injection, USP) 50 mg/10 mL (5 mg/mL) single-dose vial. The preservative-free vial is distributed by Hospira, Inc. The label highlights usage for nerve block, caudal and epidural anesthesia and indicates it is not for intrathecal anesthesia.*

FDA Label Image

Carton Ndc 0409-1582-10 (Marcaine 09)

Packaging label for Marcaine 0.5% (bupivacaine HCl injection, USP) 50 mg/10 mL (5 mg/mL) by Hospira, Inc. The label indicates 10 single-dose vials of 10 mL each, preservative-free, for nerve block, caudal, and epidural anesthesia. The label also includes storage instructions, manufacturer/distributor details, and a barcode.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Marcaine 0.5% (bupivacaine HCl) injection, USP, 150 mg/30 mL (5 mg/mL) single-dose vial, preservative free. The label specifies use for nerve block, caudal, and epidural anesthesia and states it is not for intrathecal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.*

FDA Label Image

Carton Ndc 0409-1587-50 (Marcaine 11)

Packaging label for Marcaine 0.5% bupivacaine HCl injection, USP, 150 mg/30 mL (5 mg/mL) preservative-free. Contains 10 single-dose vials of 30 mL each. Label states it is for nerve block, caudal, and epidural anesthesia, and not for intrathecal anesthesia. Distributed by Hospira, Inc., made in Sweden, with storage and usage information.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Label for Marcaine 0.75% (75 mg/10 mL) bupivacaine HCl injection, USP in a 10 mL single-dose vial. The preservative-free product is for epidural and retrobulbar anesthesia use only, explicitly stating it is not for obstetric or intrathecal anesthesia. Label includes NDC 0409-1582-18 and is distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Carton Ndc 0409-1610-50 (Marcaine 13)

Packaging label for Marcaine 0.75% bupivacaine HCl injection, USP, 75 mg/10 mL (7.5 mg/mL). The product contains 10 single-dose vials of preservative-free solution for epidural and retrobulbar anesthesia use. The label includes storage instructions, manufacturer Hospira, Inc., and states it is made in Sweden and distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label)

Label for Marcaine 0.75% (bupivacaine HCl injection, USP) 225 mg/30 mL (7.5 mg/mL) single-dose vial, preservative-free. The label states the vial volume as 30 mL and notes use for epidural and retrobulbar anesthesia, excluding obstetric or intrathecal anesthesia. It is distributed by Hospira, Inc., with storage instructions to keep at 20°C to 25°C (68°F to 77°F).*

FDA Label Image

Carton Ndc 0409-1746-10 (Marcaine 15)

Label packaging for Marcaine 0.75% bupivacaine HCl injection, USP, 225 mg/30 mL (7.5 mg/mL) single-dose vials. The label indicates it is preservative-free, intended for epidural and retrobulbar anesthesia, and not for obstetric or intrathecal anesthesia. Manufactured by Hospira, Inc.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Marcaine 0.25% (bupivacaine HCl injection, USP) 125 mg/50 mL (2.5 mg/mL) multiple-dose vial label. Contains bupivacaine HCl with methylparaben as antiseptic preservative. Label shows NDC 0409-1587-50, usage for infiltration and nerve block, storage instructions, and distribution by Hospira, Inc. Additional printed and barcode information present.*

FDA Label Image

Carton Ndc 0409-1749-10 (Marcaine 17)

Packaging label for Marcaine 0.25% (bupivacaine HCl injection, USP) 125 mg/50 mL (2.5 mg/mL) in a 50 mL multiple-dose vial. The label includes dosage information, storage instructions, and usage notes. It is distributed by Hospira, Inc. and made in Sweden. The label features multiple panels with product and manufacturer details, barcode, and space for lot and expiration date information.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Marcaine 0.5% (bupivacaine HCl injection, USP) 250 mg/50 mL (5 mg/mL) multiple-dose vial. The label indicates 50 mL vial size and contains instructions such as protection from light and storage temperature (20°C to 25°C). It notes it is not for caudal, epidural, or intrathecal anesthesia, and includes preservatives like methylparaben and antiseptic. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Carton Ndc 0409-1752-50 (Marcaine 19)

Carton label for Marcaine 0.5% (bupivacaine HCl injection, USP) 250 mg/50 mL (5 mg/mL) multiple-dose vial. Label includes dosage form, strength, ingredient details, storage instructions, and warnings including 'Not for nerve block' and not for caudal, epidural, or intrathecal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL, made in Sweden. Includes barcode and NDC 0409-1610-50.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Packaging label of Marcaine 0.25% (25 mg/10 mL) preservative-free single-dose vial. The label states the product contains 2.5 mg/mL bupivacaine hydrochloride and epinephrine injection, USP, with epinephrine 1:200,000 (as bitartrate). It is intended for infiltration, nerve block, caudal and epidural anesthesia, and is not for intrathecal anesthesia. Contains warnings about epinephrine, sulfites, storage instructions, and distributor information for Hospira, Inc.*

FDA Label Image

Carton Ndc 0409-1755-50 (Marcaine 21)

Marcaine 0.25% (25 mg/10 mL) preservative-free injection vial label by Hospira, Inc. Contains bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate). Pack includes 10 single-dose 10 mL vials. The label highlights its use for infiltration, nerve block, caudal and epidural anesthesia but states it is not for intrathecal anesthesia. Warnings include the presence of sulfites and epinephrine.*

FDA Label Image

Marcaine 22

Label for Marcaine 0.25% (75 mg/30 mL, 2.5 mg/mL) single dose vial by Hospira, Inc. The label indicates the product contains epinephrine 1:200,000 (as bitartrate), is preservative-free, and is intended for infiltration, nerve block, caudal, and epidural anesthesia. It is not for intrathecal anesthesia and warns of sulfite content. Includes dosing and storage instructions, lot and expiration placeholders, and a barcode.*

FDA Label Image

Marcaine 23

Packaging label for Marcaine 0.25% (75 mg/30 mL, 2.5 mg/mL) preservative-free injection with epinephrine 1:200,000 (as bitartrate) by Hospira, Inc. The label states it contains 30 mL in 10 single-dose vials and is indicated for infiltration, nerve block, caudal, and epidural anesthesia. It includes warnings for not using intrathecally and a sulfite warning.*

FDA Label Image

Marcaine 24

Marcaine 0.5% (50 mg/10 mL) vial label from Hospira, Inc. The label indicates it is a preservative-free, single-dose vial for nerve block, caudal, and epidural anesthesia. It contains 5 mg/mL bupivacaine hydrochloride with epinephrine 1:200,000 as bitartrate. The vial warns about epinephrine content and sulfites and states it is not for intrathecal anesthesia.*

FDA Label Image

Marcaine 25

Packaging label for Marcaine 0.5% (5 mg/mL) preservative-free injection, 50 mg/10 mL vial with epinephrine 1:200,000 (as bitartrate). The label indicates the product is for nerve block, caudal, and epidural anesthesia and warns it is not for intrathecal anesthesia. Distributed by Hospira, Inc., the carton contains 10 single-dose vials.*

FDA Label Image

Marcaine 26

Marcaine 0.5% (150 mg/30 mL) single dose vial label by Hospira, Inc. The vial is preservative-free, containing bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate). It is indicated for nerve block, caudal, and epidural anesthesia but not for intrathecal anesthesia. The label includes warnings about sulfites and instructions to discard unused portions after initial use.*

FDA Label Image

Marcaine 27

Packaging label for Marcaine 0.5% (150 mg/30 mL, 5 mg/mL) preservative-free injection by Hospira, Inc. The product contains bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate) for nerve block, caudal, and epidural anesthesia. The label emphasizes it is not for intrathecal anesthesia and contains a warning about sulfites. The package is a box containing 10 single-dose 30 mL vials.*

FDA Label Image

Marcaine 28

Marcaine 0.25% (125 mg/50 mL) multiple-dose vial label. The product contains 2.5 mg/mL bupivacaine hydrochloride and 0.0091 mg/mL epinephrine bitartrate, indicated for infiltration and nerve block injection. The label highlights it is not for caudal, epidural, or intrathecal anesthesia and includes warnings about containing epinephrine and sulfites. Distributed by Hospira, Inc.*

FDA Label Image

Marcaine 29

Packaging label for Marcaine 0.25% (125 mg/50 mL) Multiple-Dose Vial with epinephrine 1:200,000 (as bitartrate) by Hospira, Inc. The label includes dosage form and strength, active ingredients bupivacaine hydrochloride and epinephrine injection USP, storage instructions, and warnings including use for infiltration and nerve block, and contraindications for caudal, epidural, or intrathecal anesthesia.*

FDA Label Image

Marcaine 30

Marcaine 0.5% 250 mg/50 mL (5 mg/mL) multiple-dose vial label featuring bupivacaine hydrochloride and epinephrine injection, USP, indicated for nerve block. The label highlights epinephrine concentration 1:200,000 as bitartrate, warnings against autoclaving and presence of sulfites, plus storage instructions and distributor information for Hospira, Inc.*

FDA Label Image

Marcaine 31

Marcaine 0.5% (250 mg/50 mL, 5 mg/mL) multiple-dose vial packaging label by Hospira, Inc. Includes red text indicating 'with epinephrine 1:200,000 (as bitartrate)', and product details such as active ingredients bupivacaine hydrochloride and epinephrine injection USP. Additional information notes preservatives, storage instructions, usage warnings, and barcode. The label is primarily white with green, red, and black text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.